Skip to main content
Clinical Trials/ACTRN12620000802909
ACTRN12620000802909
Completed
未知

Analysis of Patient Outcomes following Platelet Rich Plasma Treatmentfor Joint Osteoarthritis

Surecell Medical Clinic0 sites1,078 target enrollmentAugust 10, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Osteoarthiritis
Sponsor
Surecell Medical Clinic
Enrollment
1078
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2020
End Date
June 7, 2019
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Surecell Medical Clinic

Eligibility Criteria

Inclusion Criteria

  • Were 18 years and over of age.
  • They received PRP treatment for pain and/or loss of function due to knee OA.
  • They received PRP treatment for pain and/or loss of function due to pes anserine bursitis.
  • They received PRP treatment for pain and/or loss of function due to ankle osteoarthritis.
  • They received PRP treatment for pain and/or loss of function due to an anterior talofibular ligament sprain.
  • They received PRP treatment for pain and/or loss of function due to an anterior talofibular ligament tear.

Exclusion Criteria

  • Were under 18 years of age.
  • Were immuno\-compromised.
  • Had a current malignancy.
  • Had a current or recent joint infection.
  • Had taken non\-steroidal anti\-inflammatory drugs 2 days before treatment or corticosteroids during the three weeks before treatment.
  • Were pregnant or breastfeeding.

Outcomes

Primary Outcomes

Not specified

Similar Trials